• OPEN AN ACCOUNT
Indian Indices
Nifty
25,461.00 55.70
(0.22%)
Sensex
83,432.89 193.42
( 0.23%)
Bank Nifty
57,031.90 239.95
( 0.42%)
Nifty IT
39,166.55 312.25
( 0.80%)
Global Indices
Nasdaq
44,849.54 344.11
(0.77%)
Dow Jones
6,298.76 50.34
(0.81%)
Hang Seng
39,792.23 6.33
(0.02%)
Nikkei 225
8,823.20 48.51
(0.55%)
Forex
USD-INR
85.63 0.05
(0.05%)
EUR-INR
100.93 0.01
(0.01%)
GBP-INR
117.11 -0.50
(-0.43%)
JPY-INR
0.60 0.00
(-0.16%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
101.444166
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
94.05
402788.36
EPS(TTM)
Face Value()
Div & Yield %
17.85
1
0.95
 

Board of Bajaj Hindusthan Sugar approves participation in Lalitpur Power Generation Company's buyback offer
Jun 30,2025
The Board of Bajaj Hindusthan Sugar at its meeting held on 30 June 2025 has approved tendering of equity shares (actual entitlement and additional shares) under the Buyback offer received from one of the group company - Lalitpur Power Generation Company for an amount upto Rs. 630.80 crore.

The proceeds to be received from the said transaction will be utilised by the Company towards payment of its Outstanding dues of Optionally Convertible Debentures (first instalment for redemption of principal amount of Optionally Convertible Debentures (OCDs), YTM and coupon interest due on 31 March 2025) to the lenders.